Large-scale testing (Phase 3)Not Yet RecruitingNCT07149467
What this trial is testing
Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study
Who this might be right for
Crohn's Disease AggravatedCrohn's Disease in Remission
Sixth Affiliated Hospital, Sun Yat-sen University 454